Physician profile
Adam Tattelbaum
NPI 1578510202
$1,076.13
in general payments reported to CMS, 2019-2025
10 companies · $391 in 2025
The $391 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $275 · 2021: $14.95 · 2022: $21.68 · 2023: $201 · 2024: $57.26 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $313.32 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Siltex Round Spectrum |
| Musculoskeletal Transplant Foundation INC. | $253.52 | 2020 | |
| Integra Lifesciences Corporation | $174.29 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $101.75 | 2023-2025 | |
| Pacira Pharmaceuticals Incorporated | $54.51 | 2023-2024 | Exparel, Iovera |
| Sientra, INC. | $49.14 | 2019 | |
| Tei Biosciences INC | $48.84 | 2019 | |
| Motiva USA, LLC | $44.13 | 2025 | |
| Allergan, INC. | $21.68 | 2022 | |
| Medtronic, INC. | $14.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Tattelbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.